I'm Tom Keen, introducing you to the new Stock Movers podcast from Bloomberg.

The show brings you short episodes, five minutes or less, covering the stocks making gains

and losses in today's trading. Subscribe to Stock Movers on Apple, on Spotify, or anywhere

you get your podcasts.

Now, here's a sample of the latest episode from our team at Bloomberg.

Bloomberg Audio Studios, Podcasts, Radio News.

The Stock Movers Podcast, Your Roundup of Companies making moves in the stock market, harnessing the power of Bloomberg data.

Well, let's take a look at some of the stocks on the move today with us as Bloomberg News Cross Asset reporter Emily Grafeo. She's here in our Bloomberg Business Week, a studio. What is on your radar today, Emily?

Okay, so it's definitely a more rotational type of day because when you look at the sector level,

consumer staples, utilities, energies,

those are the sectors that are outperforming,

whereas Infotech is one of the worst performers in the S&P 500.

When you look under the hood, I'm watching Moderna.

It's down over 7% to the lowest level since

March 2020, which is never a good barometer. I remember that. Especially if you're Moderna,

and that was before the news that, you know, you got one of the shots working for the COVID vaccine.

Right. Right. So that stock is down 30% year to date. Specifically today, we have a number of

vaccine makers falling after a top regulator at the US FDA left, which is I guess casting uncertainty

about the future of vaccines, the future of regulation. The regulator was Peter Marks and he was

overseeing the review and approval of vaccines and other medications.

He actually cited friction with the views of Robert F. Kennedy Jr.

Wall Street is saying this is kind of creating uncertainty, and it's a significant negative for biotech and biopharma, at least according to BMO capital markets.

...